Katerina Eigner Henke
Overview
Explore the profile of Katerina Eigner Henke including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Eigner S, Kleynhans J, Beckford Vera D, Sathekge M, Henke K, Ebenhan T
Sci Rep
. 2024 Aug;
14(1):19250.
PMID: 39164329
Radiolabelled puromycin analogues will allow the quantification of protein synthesis through nuclear medicine-based imaging. A particularly useful application could be the non-invasive longitudinal visualisation of mycobacterial activity through direct quantification...
2.
Pravenec M, Mlejnek P, Zidek V, Landa V, Simakova M, Silhavy J, et al.
Physiol Genomics
. 2016 Apr;
48(6):420-7.
PMID: 27113533
Resistin has been originally identified as an adipokine that links obesity to insulin resistance in mice. In our previous studies in spontaneously hypertensive rats (SHR) expressing a nonsecreted form of...
3.
Beckford Vera D, Eigner S, Henke K, Leyva Montana R, Melichar F, Beran M
Recent Results Cancer Res
. 2012 Aug;
194:301-17.
PMID: 22918766
The epidermal growth factor receptor (EGFR) is a rational target of anticancer therapies due to its overexpression in a variety of malignant epithelial tumors. Nevertheless, this antigen is also present...
4.
Eigner S, Beckford Vera D, Fellner M, Loktionova N, Piel M, Melichar F, et al.
Recent Results Cancer Res
. 2012 Aug;
194:269-83.
PMID: 22918764
Aim: Puromycin has played an important role in our understanding of the eukaryotic ribosome and protein synthesis. It has been known for more than 40 years that this antibiotic is...
5.
Eigner S, Beckford Vera D, Fellner M, Loktionova N, Piel M, Lebeda O, et al.
Mol Imaging Biol
. 2012 May;
15(1):79-86.
PMID: 22565849
Purpose: The purpose of this study was to investigate whether (44)Sc-labeled puromycin can be utilized for imaging of protein synthesis in vivo. Methods: For micro-positron emission tomographic (μPET) studies, 20-25 ...
6.
Beckford Vera D, Eigner S, Henke K, Lebeda O, Melichar F, Beran M
Nucl Med Biol
. 2011 Oct;
39(1):3-13.
PMID: 21958849
Objectives: Nimotuzumab (h-R3) is a humanized monoclonal antibody (mAb) which recognizes the external domain of the epidermal growth factor receptor (EGFR) with high specificity. It was demonstrated that h-R3 has...
7.
Vera D, Eigner S, Beran M, Henke K, Laznickova A, Laznicek M, et al.
Cancer Biother Radiopharm
. 2011 Jun;
26(3):287-97.
PMID: 21711096
Background: The humanized monoclonal antibody Nimotuzumab (h-R3) has demonstrated an exceptional and better clinical profile than other monoclonal antibodies for immunotherapy of epidermal growth factor receptor-overexpressing tumors. This work deals...